Diagramatic representation of the Q-STARZ pipeline. (A). Top: map of the landing pad vector. Bottom: scheme for generating stable transgenic ‘landing lines’. The landing pad vector is co-injected …
The recombination sites used in each vector and other salient features are indicated on each vector map.
(A) Top: schematic of the design of the landing pad bearing SHH-SBE2 as the tracking cis-regulatory element (CRE). Below: CRE activity observed exclusively in the forebrain in F1 embryos with the …
Top: tracking CREs used in the landing line. Bottom: activities of the SOX9 (A) and PAX6-SIMO (B) CREs in the landing pad highly influenced by the site of integration indicated by eGFP expression in …
Constructs carrying well-characterised CREs from the PAX6 locus (PAX6-7CE3, hindbrain enhancer, and PAX6-SIMO, lens enhancer). (A) Confocal images of 96hpf F1 embryos derived from founder lines …
Quantification data of eGFP and mCherry intensities in transgenic lines bearing the assay constructs described in Figure 3.
Images shown for pool of F1 embryos (scale bar = 1000 μm) and individual embryos (scale bar = 100 μm) at different stages of embryonic development (24–96 hr post fertilisation) derived from founder …
Replacement constructs designed with previously well-characterised enhancers from PAX6 locus (PAX6-7CE3, hindbrain enhancer, and PAX6-SIMO, lens enhancer). Images shown for pool of F1 embryos (scale …
Replacement constructs designed with previously well-characterised CREs from PAX6 locus (PAX6-7CE3, hindbrain enhancer, and PAX6-SIMO, lens enhancer). Images shown for pool of F1 embryos (scale bar …
Replacement constructs designed with previously well-characterised CREs from PAX6 locus (PAX6-7CE3, hindbrain enhancer, and PAX6-SIMO, lens enhancer). Images shown for pool of F1 embryos (scale bar …
(A) Top: schematic of assay construct with two enhancers from the mouse Shh locus active in developing forebrain (Shh-SBE2 and Shh-SBE4 driving eGFP and mCherry respectively). Below: snapshots of …
Top: position of the screening primers (SP1- 12) used for genotyping a replacement construct bearing SHH-SBE2 and SHH-SBE4 cis-regulatory elements (CREs). Bottom: PCR products obtained using the …
Dye swap experiment with SHH-SBE2 enhancer wild-type Wt(C) allele and Mut(T) allele bearing a holoprosencepaly- associated mutation (A: Wt(C)-eGFP/ Mut(T)-mCherry; B: Wt(C)-mcherry/ …
Quantification data of eGFP and mCherry intensities in transgenic lines bearing the assay constructs described in Figure 5.
The distinct expression domains of SBE2 and SBE4 enhancers in the developing forebrain are seen in green and red, respectively, while the region where their activities overlap is depicted in yellow.
Images were acquired from 54 to 69 hr post fertilisation, with a time interval of 1 hr. The distinct expression domains of SBE2 and SBE4 enhancers in the developing forebrain are seen in green and …
Images were acquired from 40 to 60 hr post fertilisation, with a time interval of 2 hr.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Commercial assay or kit | Gateway recombination cloning system | Invitrogen | 12535-019 | |
Commercial assay or kit | Phusion high fidelity polymerase | NEB | M0530S | |
Commercial assay or kit | TOPO TA Cloning Kit | Thermo Fischer Scientific | 451641 | |
Commercial assay or kit | Plasmid purification columns | QIAGEN | 12123 | |
Commercial assay or kit | PCR purification columns | QIAGEN | 28115 | |
Commercial assay or kit | SP6 mMessage mMachine kit | Ambion | AM1340 | |
Commercial assay or kit | DNeasy blood and tissue kit | QIAGEN | 69504 | |
Commercial assay or kit | T4 ligase | NEB | M020S | |
Recombinant DNA reagent | pCS2-TP (plasmid) | Bischof et al., 2007 | ||
Recombinant DNA reagent | pcDNA3.1 phiC31 (plasmid) | Addgene | Plasmid #68310 | |
Recombinant DNA reagent | NlaIII(enzyme) | NEB | R0125S | |
Recombinant DNA reagent | BfaI(enzyme) | NEB | R0568S | |
Recombinant DNA reagent | DpnII(enzyme) | NEB | R0543S | |
Chemical compound, drug | PTU (1-phenyl2-thio-urea) | Sigma-Aldrich | S515388 | |
Chemical compound, drug | Low-melting point (LMP) agarose | Sigma-Aldrich | A9414 | |
Chemical compound, drug | Tricaine | Sigma-Aldrich | MS222 | |
Software, algorithm | Imaris | Bitplane, Oxford Instruments | RRID:SCR_007370 | |
Software, algorithm | Fiji | RRID:SCR_002285 | ||
Genetic reagent | Danio rerio | Strain AB | RRID: ZIRC_ZL1 |
Details of oligonucleotides used in the study for generation of landing pads and assay constructs, and mapping of site of integration of transgene in landing lines and test lines.
Overview of transgenic lines generated in the study.